JP2010535486A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535486A5
JP2010535486A5 JP2010519503A JP2010519503A JP2010535486A5 JP 2010535486 A5 JP2010535486 A5 JP 2010535486A5 JP 2010519503 A JP2010519503 A JP 2010519503A JP 2010519503 A JP2010519503 A JP 2010519503A JP 2010535486 A5 JP2010535486 A5 JP 2010535486A5
Authority
JP
Japan
Prior art keywords
seq
leptin
polypeptide
nucleic acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010519503A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535486A (ja
Filing date
Publication date
Priority claimed from GBGB0715216.8A external-priority patent/GB0715216D0/en
Application filed filed Critical
Publication of JP2010535486A publication Critical patent/JP2010535486A/ja
Publication of JP2010535486A5 publication Critical patent/JP2010535486A5/ja
Withdrawn legal-status Critical Current

Links

JP2010519503A 2007-08-03 2008-07-23 レプチン融合タンパク質 Withdrawn JP2010535486A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0715216.8A GB0715216D0 (en) 2007-08-03 2007-08-03 Leptin
US95636007P 2007-08-16 2007-08-16
PCT/GB2008/002489 WO2009019427A1 (en) 2007-08-03 2008-07-23 Leptin fusion proteins

Publications (2)

Publication Number Publication Date
JP2010535486A JP2010535486A (ja) 2010-11-25
JP2010535486A5 true JP2010535486A5 (https=) 2011-09-15

Family

ID=38529304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010519503A Withdrawn JP2010535486A (ja) 2007-08-03 2008-07-23 レプチン融合タンパク質

Country Status (6)

Country Link
US (1) US20110092417A1 (https=)
EP (1) EP2185585A1 (https=)
JP (1) JP2010535486A (https=)
CN (1) CN101827858A (https=)
GB (1) GB0715216D0 (https=)
WO (1) WO2009019427A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2621515T (pt) 2010-09-28 2017-07-12 Aegerion Pharmaceuticals Inc Polipéptido quimérico de leptina de foca-ser humano com solubilidade aumentada
JP6006309B2 (ja) 2011-07-08 2016-10-12 アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
CN103957926B (zh) * 2011-07-08 2018-07-03 安米林药品有限责任公司 具有增强的作用持续时间和降低的免疫原性的工程改造的多肽
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
TW202417497A (zh) 2015-10-12 2024-05-01 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
LT3538554T (lt) 2016-11-08 2025-10-10 Antigeną surišantys baltymai, antagonizuojantys leptino receptorius
SG11202005146VA (en) 2017-12-18 2020-06-29 Regeneron Pharma Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
PT3773713T (pt) 2018-04-06 2025-07-29 Regeneron Pharma Anticorpo agonista do recetor de leptina para usar no aumento da massa óssea num sujeito que sofre de disfunção metabólica ou de hipoleptinemia
CN109942716B (zh) * 2019-04-08 2023-05-12 河南师范大学 一种用于治疗代谢疾病的瘦素融合蛋白及其制备方法和应用
CN111848774B (zh) * 2020-08-05 2022-05-10 武汉海特生物制药股份有限公司 一种美曲普汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
EP1290170A2 (en) * 2000-06-16 2003-03-12 Asterion Limited Binding agents: chimeric ligand/receptor proteins
EP1771467A2 (en) * 2004-07-26 2007-04-11 Asterion Limited Linkers
WO2007080404A2 (en) * 2006-01-12 2007-07-19 Asterion Limited Leptin ligand

Similar Documents

Publication Publication Date Title
JP2010535486A5 (https=)
JP2017527272A5 (https=)
TWI248444B (en) FAP-activated anti-tumour compounds
JP2023506454A5 (https=)
CA3072051A1 (en) Affinity-based methods for using transferrin receptor-binding proteins
WO2008000516B1 (en) IMPROVED sgp130Fc DIMERS
JP2013507930A5 (https=)
JP2023528207A5 (https=)
JP2020503262A5 (ja) アクチビンIIa型受容体変異体および同変異体を含む医薬組成物
FI3368555T3 (fi) Kaksitoimisia proteiineja ja niitä sisältävä farmaseuttinen koostumus
JP2014524908A5 (https=)
WO2014130722A1 (en) Methods and compositions for treatment of forbes-cori disease
JP2011526303A5 (https=)
RU2014101697A (ru) Коагонисты рецепторов глюкагона/glp-1
JP2019507589A5 (https=)
JP2008503217A5 (https=)
JP2007505643A5 (https=)
JP2010526551A5 (https=)
JP2017533194A5 (https=)
HRP20240135T1 (hr) Fgf21 mutanti i njihove upotrebe
JP2014508510A5 (https=)
EA020091B1 (ru) Аналоги глюкозозависимого инсулинотропного полипептида (gip), модифицированные по n-концу
JP2016512213A5 (https=)
RU2009148020A (ru) ОПТИМИЗИРОВАННЫЙ СЛИТЫЙ БЕЛОК TACI-Fc
RU2018119141A (ru) Слитые с fgf21 белки длительного действия и содержащая их фармацевтическая композиция